Uzbekistan. Pharmaceutical industry and market environment
The country features high natural demographic growth rates, which total 1-1.5% per annum according to the projections. Approximately 615,000 newborns are expected annually in the next five years, whereas, 607,800 are expected annually in 2015-2020, and 596,700 annually in 2020-2025. Also absolute growth of the number of the elderly is expected thanks to the improvement of health services and better living standards.
These factors lead to higher demand for medications essential for treatment of pediatric diseases, mandatory vaccination of newborns and children, and treatment of diseases typical for the elderly – cardiovascular, oncological, and neurological diseases.
Today the pharmaceutical market of Uzbekistan totals approximately USD 500 million and features quite high growth rates, approximately 10% per annum. Along with aforementioned demographic factors, improving public welfare and changes in the preferences, further sustainable development of the sector is expected. Provided that domestic demand grows 10-15 percent annually, the market may exceed USD 1 billion in nearest years.
Notably the priorities of the Government of Uzbekistan, focused on comprehensive modernization of health system, the main consumer of the market of medical drugs and health products unveil new opportunities for investing into this sector.
Today over 1,000 inpatient health institutions, 4,000 polyclinics and outpatient institutions, 501 rural outpatient posts, 2,606 rural health clinics (RHC) and other health institutions are providing qualified public health services.
Thus, along with demographic growth, longer life expectancy, and increasing aging of population, and advancement of public health system, inter alia, thanks to the growth of health institutions, the need for medical drugs is increasing. Thus, the pharmaceutical sector has major development prospects.
These factors lead to higher demand for medications essential for treatment of pediatric diseases, mandatory vaccination of newborns and children, and treatment of diseases typical for the elderly – cardiovascular, oncological, and neurological diseases.
Today the pharmaceutical market of Uzbekistan totals approximately USD 500 million and features quite high growth rates, approximately 10% per annum. Along with aforementioned demographic factors, improving public welfare and changes in the preferences, further sustainable development of the sector is expected. Provided that domestic demand grows 10-15 percent annually, the market may exceed USD 1 billion in nearest years.
Notably the priorities of the Government of Uzbekistan, focused on comprehensive modernization of health system, the main consumer of the market of medical drugs and health products unveil new opportunities for investing into this sector.
Today over 1,000 inpatient health institutions, 4,000 polyclinics and outpatient institutions, 501 rural outpatient posts, 2,606 rural health clinics (RHC) and other health institutions are providing qualified public health services.
Thus, along with demographic growth, longer life expectancy, and increasing aging of population, and advancement of public health system, inter alia, thanks to the growth of health institutions, the need for medical drugs is increasing. Thus, the pharmaceutical sector has major development prospects.
Source: UNDP
Leave a Comment